Lidocaine 5% Patch Supplementation to Intra-articular Bupivacaine Dexmedetomidine After Arthroscopic Knee Surgery

• Status: Completed
• Trial end date: 2017-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Surgery of the knee is a very common procedure which can be very painful and sufficient postoperative pain treatment is often problematic. The aim of this work was to study the effects of supplementation of intra-articular bupivacaine dexmedetomidine with lidocaine 5% patch after arthroscopic knee surgery under general anesthesia and its role in improving quality of anesthesia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tanta University
• Treatments: Bupivacaine; Dexmedetomidine; Lidocaine

Criteria

Inclusion Criteria:

• Adult patients

• ASA I & II

• Aged between 18 to 60 years

• Weight between 60 to 100 kg

• Scheduled for elective arthroscopic knee surgery

Exclusion Criteria:

• patient refusal.

• history of cardiac disease.

• impaired renal or hepatic function.

• hypertension treated with α methyldopa, clonidine, or beta-adrenergic blockers.

• if they have used opioid analgesics within the previous 24 hr.

• previous sensitivity to local anesthetics.